Class II

Drug Recall: Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01

Leading Pharma, LLC · March 20, 2026

Reason for Recall

CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

Distribution

US Nationwide.

States Affected

NATIONWIDE

Quantity Affected

9384 bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0486-2026

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.